Back to search

University of Glasgow

In Vitro Regulation of the Progesterone Receptor

Abstract

dc:description.abstract

The single commonest cause of cancer deaths among women is breast cancer, closely followed by lung cancer. As detection methods and treatments improve, the rate of breast cancer deaths will hopefully fall. Surgical removal of all clinically apparent disease is usually the treatment of primary breast cancer, often followed by adjuvant systemic treatments to treat subclinical metastases. There are several appropriate adjuvant systemic treatments, however, the one favoured for hormonally sensitive cancer is endocrine therapy. This treatment is based on the concept that certain tumour cells will retain their sensitivity to hormones (e.g. oestrogen and progesterone). The aim of this type of therapy must therefore be to negate or reverse the proliferative effects of such influential hormones. While it is accepted by clinicians that antiestrogens and progestins provide effective treatment of advanced hormone-sensitive breast cancer, long term usage leads to drug resistance and relapse. A possible approach to overcoming the mechanism of resistance could be to use short bursts of alternative endocrine therapies. Leake et al., (1992) demonstrated that a treatment with Tamoxifen and Megace could give significant advantages when compared to Tamoxifen alone. However, at the end of the progestin component of the cycle there was onset of vaginal bleeding in 13% of patients. One possible solution could be the maintenance of a low level of Norethisterone (10e-9M) through out the cycle. Studies contained within this thesis demonstrated that the Tamoxifen component of the cycle induced PR synthesis in ZR-75-1 cells. The ability of Tamoxifen to maintain PR synthesis was not impaired by the presence of Norethisterone (1x10e-9M). However, higher doses of this progestin did significantly reduce PR levels. Investigations into the effect of Tamoxifen and progestin either alone or together on the proliferation on ZR-75-1 or MCF-7 cells revealed that Tamoxifen induced cell growth. Norethisterone plus Tamoxifen had no effect on either cell line. However, on its own, Norethisterone induced some growth inhibition on MCF-7 cells.

Degree

thesis:*
Level dc:type.qualificationlevel
MSc(R)
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
1994

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Fox, Mark

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Fox, Mark. In Vitro Regulation of the Progesterone Receptor. MSc(R) thesis, University of Glasgow, 1994.